Our Work
Latham & Watkins Advises on ENOUGH’s €42 Million Series B
July 2, 2021
London emerging companies team represents investor, CPT Capital, in the food tech funding round.
Latham & Watkins advised CPT Capital on its investment in food tech startup ENOUGH’s (formerly 3F BIO) €42 million Series B funding round.
ENOUGH produces ABUNDA® mycoprotein, fermenting fungi using renewable feedstocks to make the most sustainable source of food protein. ENOUGH targets growing over a million tonnes by 2032 which is the equivalent of replacing 5 million cows, over 1 billion chickens or reducing more than 6 million tonnes of CO2 emissions, the equivalent of planting >30 million trees. ABUNDA is sustainable through its advantaged feed conversion, low carbon footprint and water usage.
The Latham team was led by London corporate
partners Shing Lo and Robbie McLaren, with associate Samantha Peacock.